Search Results 1161-1170 of 18669 for Relapse
Has failed to respond to, relapsed following, not eligible, or opted not to participate in bone marrow transplantation. Off all other treatments for MDS for ...
... relapse (Phase I), and to determine the antitumor effectiveness of the combination of NMS-03305293 and TMZ in patients with isocitrate dehydrogenase (IDH) ...
In addition, the research group performs large multicenter trials of ECT efficacy and methods to prevent patient relapse after ECT treatment. Paul E ...
Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin lymphoma featured. Cancer. Mayo Clinic to offer CAR T-cell therapy for relapsed non-Hodgkin ...
Latest stories ; In the Loop: Adult stem cells as treatment of the future featured image. Cardiovascular ; Mayo Clinic to offer CAR T-cell therapy for relapsed ...
This phase II trial studies how well ibrutinib works in treating patients with relapsed hairy cell leukemia. Ibrutinib may stop the growth of cancer cells ...
Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...
The purpose of this study is to evaluate the safety and tolerability of LYL797, a ROR1-targeted CAR T-cell therapy, in patients with ROR1+ relapsed or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.